Lassman HB

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (3)

Title : Multiple dose pharmacokinetics, safety, and tolerance of velnacrine (HP 029) in healthy elderly subjects: a potential therapeutic agent for Alzheimer's disease - Puri_1990_J.Clin.Pharmacol_30_948
Author(s) : Puri SK , Ho I , Hsu R , Lassman HB
Ref : Journal of Clinical Pharmacology , 30 :948 , 1990
Abstract : Puri_1990_J.Clin.Pharmacol_30_948
ESTHER : Puri_1990_J.Clin.Pharmacol_30_948
PubMedSearch : Puri_1990_J.Clin.Pharmacol_30_948
PubMedID: 2229455

Title : The effect of food on the bioavailability of velnacrine (HP 029) in healthy elderly men: a potential Alzheimer agent - Puri_1989_J.Clin.Pharmacol_29_956
Author(s) : Puri SK , Hsu RS , Ho I , Lassman HB
Ref : Journal of Clinical Pharmacology , 29 :956 , 1989
Abstract : Puri_1989_J.Clin.Pharmacol_29_956
ESTHER : Puri_1989_J.Clin.Pharmacol_29_956
PubMedSearch : Puri_1989_J.Clin.Pharmacol_29_956
PubMedID: 2592587

Title : Single dose safety, tolerance, and pharmacokinetics of HP 029 in healthy young men: a potential Alzheimer agent - Puri_1989_J.Clin.Pharmacol_29_278
Author(s) : Puri SK , Hsu RS , Ho I , Lassman HB
Ref : Journal of Clinical Pharmacology , 29 :278 , 1989
Abstract : Puri_1989_J.Clin.Pharmacol_29_278
ESTHER : Puri_1989_J.Clin.Pharmacol_29_278
PubMedSearch : Puri_1989_J.Clin.Pharmacol_29_278
PubMedID: 2723116